Participate in PROTEA Studies

Learn about current studies and see if you are eligible to enroll.

Psilocybin for Opioid Use Disorder (HOUDI Study)

About the Study: The primary objective of this clinical trial is to determine the safety of psilocybin in adult patients with opioid use disorder concurrently taking buprenorphine-naloxone. (Full study details at ClinicalTrials.gov)

Participants may receive up to $595.

 Eligibility Requirements: participants with opioid use disorder, between the ages of 21-65 in the Madison and surrounding area..

How to Enroll: Complete this survey »

Methylone for PTSD

About the study: The EMPOWER Study is a clinical trial exploring a new oral investigational medication for people experiencing symptoms of post-traumatic stress disorder (PTSD). (https://www.joinempowerstudy.com/)

Eligibility Requirements: You have experienced a traumatic event and are suffering from symptoms of PTSD and are at least 18 years old.

How to Enroll: https://www.joinempowerstudy.com/